chr1-113896403-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001253852.3(AP4B1):​c.1365T>C​(p.Tyr455Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.019 in 1,614,204 control chromosomes in the GnomAD database, including 348 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 24 hom., cov: 33)
Exomes 𝑓: 0.019 ( 324 hom. )

Consequence

AP4B1
NM_001253852.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.18

Publications

4 publications found
Variant links:
Genes affected
AP4B1 (HGNC:572): (adaptor related protein complex 4 subunit beta 1) This gene encodes a subunit of a heterotetrameric adapter-like complex 4 that is involved in targeting proteins from the trans-Golgi network to the endosomal-lysosomal system. Mutations in this gene are associated with cerebral palsy spastic quadriplegic type 5 (CPSQ5) disorder. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
AP4B1-AS1 (HGNC:44114): (AP4B1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 1-113896403-A-G is Benign according to our data. Variant chr1-113896403-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 157717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0143 (2183/152314) while in subpopulation NFE AF = 0.0229 (1560/68024). AF 95% confidence interval is 0.022. There are 24 homozygotes in GnomAd4. There are 1012 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP4B1NM_001253852.3 linkc.1365T>C p.Tyr455Tyr synonymous_variant Exon 8 of 10 ENST00000369569.6 NP_001240781.1 Q9Y6B7-1A0A024R0J5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP4B1ENST00000369569.6 linkc.1365T>C p.Tyr455Tyr synonymous_variant Exon 8 of 10 1 NM_001253852.3 ENSP00000358582.1 Q9Y6B7-1

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2183
AN:
152196
Hom.:
24
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00400
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0149
Gnomad ASJ
AF:
0.00979
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.00579
Gnomad FIN
AF:
0.0116
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0229
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.0152
AC:
3816
AN:
251280
AF XY:
0.0158
show subpopulations
Gnomad AFR exome
AF:
0.00295
Gnomad AMR exome
AF:
0.0101
Gnomad ASJ exome
AF:
0.0101
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0103
Gnomad NFE exome
AF:
0.0243
Gnomad OTH exome
AF:
0.0176
GnomAD4 exome
AF:
0.0195
AC:
28474
AN:
1461890
Hom.:
324
Cov.:
32
AF XY:
0.0195
AC XY:
14169
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.00293
AC:
98
AN:
33480
American (AMR)
AF:
0.0111
AC:
498
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0108
AC:
283
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00722
AC:
623
AN:
86258
European-Finnish (FIN)
AF:
0.0123
AC:
658
AN:
53420
Middle Eastern (MID)
AF:
0.0111
AC:
64
AN:
5768
European-Non Finnish (NFE)
AF:
0.0227
AC:
25288
AN:
1112010
Other (OTH)
AF:
0.0159
AC:
961
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1770
3539
5309
7078
8848
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
888
1776
2664
3552
4440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0143
AC:
2183
AN:
152314
Hom.:
24
Cov.:
33
AF XY:
0.0136
AC XY:
1012
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00399
AC:
166
AN:
41580
American (AMR)
AF:
0.0148
AC:
227
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00979
AC:
34
AN:
3472
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5186
South Asian (SAS)
AF:
0.00580
AC:
28
AN:
4830
European-Finnish (FIN)
AF:
0.0116
AC:
123
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0229
AC:
1560
AN:
68024
Other (OTH)
AF:
0.0180
AC:
38
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
111
222
332
443
554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0193
Hom.:
20
Bravo
AF:
0.0149
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.0236
EpiControl
AF:
0.0236

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 04, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 01, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia 47 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 07, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Hereditary spastic paraplegia Benign:1
May 23, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
3.1
DANN
Benign
0.73
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114201291; hg19: chr1-114439025; API